REVVITY, INC Cash and Restricted Cash
REVVITY, INC (RVTY) had Cash and Restricted Cash of $1.02 billion as of 2026-07-05, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-11
- 2026-07-05: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.02B.
- 2026-04-05: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $861.47M.
- 2025-12-28: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $921.03M.
- 2025-09-28: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $932.58M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-07-05 | $1.02B 10-Q · filed 2026-08-11 | |
| 2026-04-05 | $861.47M 10-Q · filed 2026-05-12 | |
| 2025-12-28 | $921.03M 10-Q · filed 2026-08-11 | |
| 2025-09-28 | $932.58M 10-Q · filed 2025-11-04 | |
| 2025-06-29 | $992.99M 10-Q · filed 2026-08-11 | |
| 2025-03-30 | $1.14B 10-Q · filed 2026-05-12 | |
| 2024-12-29 | $1.16B 10-Q · filed 2026-08-11 | |
| 2024-09-29 | $1.23B 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $1.25B 10-Q · filed 2025-08-05 | |
| 2024-03-31 | $999.47M 10-Q · filed 2025-05-06 | |
| 2023-12-31 | $914.37M 10-K · filed 2026-02-24 | |
| 2023-10-01 | $1.14B 10-Q · filed 2024-11-06 | |
| 2023-07-02 | $1.33B 10-Q · filed 2024-08-06 | |
| 2023-04-02 | $2.27B 10-Q · filed 2024-05-07 | |
| 2023-01-01 | $470.75M 10-K · filed 2026-02-24 | |
| 2022-10-02 | $416.31M 10-Q · filed 2023-11-07 | |
| 2022-07-03 | $361.93M 10-Q · filed 2023-08-09 | |
| 2022-04-03 | $670.75M 10-Q · filed 2023-05-12 | |
| 2022-01-02 | $619.34M 10-K · filed 2025-02-25 | |
| 2021-10-03 | $489.06M 10-Q · filed 2022-11-14 | |
| 2021-07-04 | $726.70M 10-Q · filed 2022-08-09 | |
| 2021-04-04 | $990.40M 10-Q · filed 2022-05-10 | |
| 2021-01-03 | $402.61M 10-K · filed 2024-02-27 | |
| 2020-10-04 | $258.40M 10-Q · filed 2021-11-09 | |
| 2020-07-05 | $219.94M 10-Q · filed 2021-08-10 | |
| 2020-04-05 | $195.17M 10-Q · filed 2021-05-11 | |
| 2019-12-29 | $191.89M 10-K · filed 2023-03-01 | |
| 2019-09-29 | $395.98M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $153.22M 10-Q · filed 2020-08-11 | |
| 2019-03-31 | $137.46M 10-Q · filed 2020-05-12 | |
| 2018-12-30 | $166.31M 10-K · filed 2022-03-03 | |
| 2018-09-30 | $152.72M 10-Q · filed 2019-11-05 | |
| 2018-07-01 | $163.60M 10-Q · filed 2019-08-06 | |
| 2018-04-01 | $181.00M 10-Q · filed 2019-05-07 | |
| 2017-12-31 | $202.37M 10-K · filed 2021-03-02 | $202.37M 10-Q · filed 2018-05-08 |
| 2017-10-01 | $709.72M 10-Q · filed 2018-11-06 | |
| 2017-07-02 | $616.56M 10-Q · filed 2018-08-07 | |
| 2017-04-02 | $290.63M 10-Q · filed 2018-05-08 | |
| 2017-01-01 | $376.57M 10-K · filed 2020-02-25 | |
| 2016-01-03 | $238.27M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |